Our customers' Feedback
Search:
Perform search
Categories list

Generic Reminyl

News
Reminyl

Generic Reminyl (Galantamine)

Alzheimer's And Parkinson's

PackagePricePer PillSavingsOrder
4mg × 10 pills$24.95$2.50Add to cart
4mg × 20 pills$39.95$2.00$9.95Add to cart
4mg × 30 pills$54.95$1.83$19.90Add to cart
4mg × 60 pills$99.95$1.67$49.75Add to cart
4mg × 90 pills$144.95$1.61$79.60Add to cart
4mg × 120 pills$189.95$1.58$109.45Add to cart

PackagePricePer PillSavingsOrder
8mg × 10 pills$44.95$4.50Add to cart
8mg × 20 pills$69.95$3.50$19.95Add to cart
8mg × 30 pills$89.95$3.00$44.90Add to cart
8mg × 60 pills$174.95$2.92$94.75Add to cart
8mg × 90 pills$259.95$2.89$144.60Add to cart
8mg × 120 pills$319.95$2.67$219.45Add to cart

Most popular quantity.
Requip
$ 0.67
Generic Requip
(Ropinirole 0.25/0.5/1/2mg)
Sinemet
$ 0.57
Generic Sinemet
(Carbidopa - Levodopa 10mg + 100/25mg + 100/25mg + 250mg)
Sinemet Cr
$ 0.96
Generic Sinemet Cr
(Carbidopa - Levodopa 50mg + 200mg)
Stalevo
$ 0.72
Generic Stalevo
(Carbidopa Levodopa Entacapone 25mg + 100mg + 200mg)
Symmetrel
$ 1.11
Generic Symmetrel
(Amantadine 100mg)
Aricept
$ 0.89
Generic Aricept
(Donepezil 5/10mg)
Social bookmarks:
Choose your language:



Money backguarantee
Secureshopping

Our billing is certified by:

Secure shopping certificates

Special Offer!

  • Takeda renames antidepressant after name confusion leads to errors - BioPharma Dive

    Takeda renames antidepressant after name confusion leads to errorsBioPharma DiveIn 2005, Johnson & Johnson changed the name of its medication for mild-to-moderate Alzheimer's disease Reminyl to Razadyne in order to avoid confusion with the antidiabetic drug Amaryl (glimepiride).

  • Wees alert op huidreacties bij Reminyl® - Nursing. Platform voor verpleegkundigen

    Nursing.

  • Dementia drugs Aricept, Exelon and Reminyl may put some patients at risk - News-Medical.net

    Dementia drugs Aricept, Exelon and Reminyl may put some patients at riskNews-Medical.

  • Razadyne/Reminyl (Alzheimer's Disease) - Forecast and Market Analysis to 2022 - PR Newswire (press release)

    Razadyne/Reminyl (Alzheimer's Disease) - Forecast and Market Analysis to 2022PR Newswire (press release)GlobalData has released its new PharmaPoint Drug Evaluation report, 'Razadyne/Reminyl (Alzheimer's Disease) - Forecast and Market Analysis to 2022'.

  • Reminyl : risque de réactions cutanées graves - 16/10/2015 - Le Moniteur des pharmacies

    Reminyl : risque de réactions cutanées graves - 16/10/2015Le Moniteur des pharmaciesL'agence nationale de sécurité du médicament et des produits de santé (ANSM) a publié une nouvelle mise en garde concernant Reminyl (bromhydrate de galantamine) et ses génériques, indiqué dans le traitement symptomatique de la maladie d'Alzheimer .

    Copyright © cheapgenerics24.com